MSCI ACWI IMI Immuno-Oncology Index

The MSCI ACWI IMI Immuno-oncology Index aims to represent the performance of a set of companies that are associated with research, development, and commercialization of products for cancer immunotherapy, also known as Immuno-oncology. Immuno-oncology is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control and eliminate cancer.
Index code
752570
Index type
Equity
Benchmark administrator
--
Div Yld (%)
2.17
P/E
36.56
P/E Fwd
25.58
P/BV
4.25
Number of constituents
48
Index Market Cap
$2.41 T
Largest constituent Market Cap
$199.00 B
Smallest constituent Market Cap
$1.61 B
Average constituent Market Cap
$50.36 B
Median constituent Market Cap
$23.56 B
Does this benchmark pursue ESG objectives?
No
Data as of July 31, 2025 

Want to learn more about MSCI indexes?
Get in touch.